Cell technologies in reproductology, obstetrics and gynecology

Home/2013, Vol. 1, No. 1/Cell technologies in reproductology, obstetrics and gynecology

Cell and Organ Transplantology. 2013; 1(1):61-65.
DOI: 10.22494/COT.V1I1.46

Cell technologies in reproductology, obstetrics and gynecology

Nasadyuk C. M.
Institute of Cell Therapy, Кyiv, Ukraine

The review describes the current trends of the development of cell and gene technologies in obstetrics, gynecology and reproductive medicine. The strategies of allogeneic and autologous hematopoietic stem cell transplantation in the myeloablative treatment of germinal tumors and breast cancer are considered, as well as adoptive immunotherapy, modern approaches to the treatment of female and male infertility, and also prenatal cell and gene therapy. The problems and achievements in uterus transplantation are described, as well as the successes in the cryopreservation of reproductive cells and tissues.

Full Text PDF

1. Akar M, Ozkan O, Erdogan O, et al. Uterus transplantation from a deceased donor. Fertil Steril. 2013. http://www.ncbi.nlm.nih.gov/pubmed/23880349.
2. Baughman J, Geijsen N. In vitro generation of germ cells: new techniques to solve current issues. Ann NY Acad Sci. 2005; 1061:33-40.
3. Binart N, Sauvat F. Cryopreserved ovaries: models of experimental grafting. Biol Aujourdhui. 2011; 205(4):235–43.
4. Bukovsky A, Copas P, Virant-Klun I. Potential new strategies for the treatment of ovarian infertility and degenerative diseases with autologous ovarian stem cells. Expert Opin Biol Ther. 2006; 6(4):341-65.
5. Cervelloґ I, Gil-Sanchis C, Aymara Mas et al. Human Endometrial Side Population Cells Exhibit Genotypic, Phenotypic and Functional Features of Somatic Stem Cells. PLoS One. 2010; 5(6):1–15.
6. Chao K, Yang H, Chen M. Human umbilical cord mesenchymal stem cells suppress breast cancer tumourigenesis through direct cell-cell contact and internalization. J Cell Mol Med. 2012; 16(8):1803–15.
PMid:21973190 PMCid:PMC3822693
7. Conese M, Ascenzioni F, Boyd A, et al. Gene and cell therapy for cystic fibrosis: from bench to bedside. J. Cyst. Fibros. – 2011. – 10, suppl 2:114 – 128.
8. David AL, Waddington SN. Candidate diseases for prenatal gene therapy. Methods Mol Biol. 2012; 891:9-39.
9. Demirer T, Barkholt L, Blaise D, et al. Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors. Nat Clin Pract Oncol. 2008; 5(5):256-67.
10. Díaz-García C, Akhi S, Wallin A, et al. First report on fertility after allogeneic uterus transplantation. Acta Obstet Gynecol Scand. 2010; 89(11):1491-4.
11. Du H, Taylor H. Stem cells and reproduction. Curr Opin Obstet Gynecol. 2010; 22(3):235-41.
PMid:20305558 PMCid:PMC3107846
12. Dunlop C, Telfer E, Anderson R. Ovarian stem cells – potential roles in infertility treatment and fertility preservation. Maturitas. 2013.
13. Easley C., Simerly C, Schatten G. Stem cell therapeutic possibilities: future therapeutic options for male-factor and female-factor infertility?. Reprod Biomed Online. 2013; 27(1):75-80.
PMid:23664220 PMCid:PMC3703485
14. Fageeh W, Raffa H, Jabbad H, et al. Transplantation of the human uterus. Int J Gynaecol Obstet. 2002; 76(3):245-51.
15. Fish J. Fertility preservation for adolescent women with cancer. Adolesc Med State Art Rev. 2012; 23(1):111-22.
16. Fridriksdottir A, Petersen O., Rønnov-Jessen L. Mammary gland stem cells: current status and future challenges. Int J Dev Biol. 2011; 55(7–9):719-29.
17. Gargett CE, Masuda H. Adult Stem Cells in the Endometrium. Mol Hum Reprod. 2010; 16(11):818-834.
18. Gray F., Turner C, Ahmed A, et al. Prenatal tracheal reconstruction with a hybrid amniotic mesenchymal stem cells-engineered construct derived from decellularized airway. J Pediatr Surg. 2012; 47(6):1072–9.
19. Hartmann K, Raabe O, Wenisch S, et al. Amniotic fluid derived stem cells give rise to neuron-like cells without a further differentiation potential into retina-like cells. Am J Stem Cells. 2013; 2(2):108-18.
PMid:23862099 PMCid:PMC3708508
20. Hu W, Wang J, He X, et al. Human umbilical blood mononuclear cell-derived mesenchymal stem cells serve as interleukin-21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice. Biotechnol Appl Biochem. 2011; 58(6):397–404.
21. Johnson J, Bagley J, Skaznik-Wikiel M, et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell. 2005; 122:303–15.
22. Johnson J, Canning J, Kaneko T, et al. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004; 428:145-50.
23. Kang N.H, Yi B.R, Lim S.Y, et al. Human amniotic membrane-derived epithelial stem cells display anticancer activity in BALB/c female nude mice bearing disseminated breast cancer xenografts. Int J Oncol. 2012. 40(6):2022–8.
24. Kisu I, Banno K, Mihara M, et al. Current status of uterus transplantation in primates and issues for clinical application. Fertil Steril. 2013; 100(1):280–94.
25. Kisu I, Mihara M, Banno K, et al. Risks for Donors in Uterus Transplantation. Reprod Sci. 2013. http://www.ncbi.nlm.nih.gov/pubmed/23793471.
26. Krotz SP, Robins JC, Ferruccio TM, et al. In vitro maturation of oocytes via the pre-fabricated self-assembled artificial human ovary. J Assist Reprod Genet. 2010; 27(12):743-50.
PMid:20737203 PMCid:PMC2997950
27. Lee HJ, Selesniemi K, Niikura Y, et al. Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. J. Clin. Oncol. 2007; 25(22):3198-204.
28. Li P, Hu H, Yang S, et al. Differentiation of induced pluripotent stem cells into male germ cells in vitro through embryoid body formation and retinoic acid or testosterone induction. Biomed Res Int. – 2013. http://www.ncbi.nlm.nih.gov/pubmed/23509752.
29. Maggiulli R, Neri Q, Monahan D, et al. What to do when ICSI fails. Syst Biol Reprod Med. 2010; 56(5):376–87.
30. Mátrai Z, Pesthy P, Gulyás G, et al. Autologous fat transplantation in the modern reconstructive surgery of breast cancer. Orv Hetil. 2012; 153(46):1816–31.
31. Möbus V, Wandt H, Frickhofen N, et al. Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT. J Clin Oncol. 2007; 25(27):4187–93.
32. Müller A. Keller K, Wacker J, et al. Retransplantation of cryopreserved ovarian tissue: the first live birth in Germany. Dtsch Arztebl Int. 2012; 109(1-2):8–13.
PMid:22282711 PMCid:PMC3265981
33. Nabhan S., Bitencourt M, Duval M, et al. Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patients. Haematologica. 2010; 95(10):1783-7.
PMid:20494929 PMCid:PMC2948106
34. Conti M, Giudice L. From stem cells to germ cells and back again. Nature medicine. 2008; 14(11):1188–90.
35. Oktem O, Oktay K. Stem cells: a perspective on oocytes. Ann NY Acad Sci. 2008; 1127:20-6.
36. Pedrazzoli P, Martinelli G. Proceedings of the 36th annual Meeting of the European Group for Blood and Marrow Transplantation. 2010 March 21-24. Vienna, Austria. NPG. 2010.
37. Pedrazzoli P, Rosti G, Secondino S et al. High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults. Semin Hematol. 2007; 44(4):286–95.
38. Perillo A, Bonanno G, Pierelli L, et al. Stem cells in gynecology and obstetrics. Panminerva Med. 2004; 46(1):49-59.
39. Perillo A, Ferrandina G, Pierelli L, et al. Stem cell-based treatments for gynecological solid tumors. Eur Rev Med Pharmacol Sci. 2005; 9(2):93-102.
40. Perillo A, Pierelli L, Scambia G, et al. The role of hematopoietic stem cells in the treatment of ovarian cancer. Panminerva Med. 2002; 44(3):197–204.
41. Poirot C, Schubert B. Fertility preservation in prepubertal children. Bull Cancer. 2011; 98(5):489–99.
42. Poirot , Abirached F, Prades M, et al. Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet. 2012; 379:588.
43. Ringdén O. Immunotherapy by allogeneic stem cell transplantation. Adv Cancer Res. 2007; 97:25–60.
44. Roybal J, Laje P, Vrecenak J, et al. Use of manipulated stem cells for prenatal therapy. Methods Mol Biol. 2012; 891:169–81.
45. Sun M, Wang S, Li Y, et al. Adipose-derived stem cells improved mouse ovary function after chemotherapy-induced ovary failure. Stem Cell Res Ther. 2013; 4(4):80.
PMid:23838374 PMCid:PMC3854877
46. Surbek D, Gratwohl A, Holzgreve W. In utero hematopoietic stem cell transfer: current status and future strategies. Eur J Obstet Gynecol Reprod Biol. 1999; 85(1):109–15.
47. Surbek D, Holzgreve W. Prenatal stem cell transplantation: from bench to bedside. Ther Umsch. – 2002; 59(11):619–23.
48. Surbek D, Holzgreve W, Nicolaides K. Haematopoietic stem cell transplantation and gene therapy in the fetus: ready for clinical use?. Hum Reprod Update. 2001; 7(1):85–91.
49. Yang R, Xiong C. Application prospect of adult stem cells in male infertility. Zhonghua Nan Ke Xue. 2013; 19(5):468–71.

Nasadyuk CM. Cell technologies in reproductology, obstetrics and gynecology. Cell and Organ Transplantology. 2013; 1(1):61-65. doi: 10.22494/COT.V1I1.46


Creative Commons License
Is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.